Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Peggy J de Vos van Steenwijk"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Hans Gelderblom, Sjoerd H van der Burg, Ferry Ossendorp, Peggy J de Vos van Steenwijk, Mariette I E van Poelgeest, Inge Roozen, Willem-Jan Krebber, Cornelis J M Melief, Frank M Speetjens, Marij J P Welters, Nikki M Loof, Sanne Boekestijn, Catharina A H Janssen, Marije Slingerland, Gijs G Zom, A Rob P M Valentijn, Nico J Meeuwenoord, Gijs A van der Marel, Dmitri V Filippov
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Amplivant is a molecularly optimized Toll-like receptor 2 ligand that can be covalently conjugated to tumor peptide antigens. In preclinical models, amplivant-adjuvanted synthetic long peptides (SLPs) strongly enhanced antigen presentation
Externí odkaz:
https://doaj.org/article/116d0102ba984134b3b45409c8b1b84b
Autor:
Ziena Abdulrahman, Noel de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Marij J. P. Welters, Mariette I E van Poelgeest
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundVulvar high-grade squamous intraepithelial lesion (vHSIL) is predominantly induced by high-risk human papilloma virus type 16 (HPV16). In two independent trials, therapeutic vaccination against the HPV16 E6 and E7 oncoproteins resulted in o
Externí odkaz:
https://doaj.org/article/0e0d2f0ef1a04f048f971b6ef0646463
Autor:
Natasja Hendriks, Margot M. Koeneman, Anna J.M. van de Sande, Charlotte G.J. Penders, Jurgen M.J. Piek, Loes F.S. Kooreman, Sander M.J. van Kuijk, Linde Hoosemans, Simone J.S. Sep, Peggy J. de Vos Van Steenwijk, Heleen J. van Beekhuizen, Brigitte F.M. Slangen, Hans W. Nijman, Roy F.P.M. Kruitwagen, Arnold-Jan Kruse
Publikováno v:
Journal of Immunotherapy, 45(3), 180-186. LIPPINCOTT WILLIAMS & WILKINS
Journal of Immunotherapy, 45(3), 180-186. Lippincott Williams & Wilkins
Journal of Immunotherapy, 45(3), 180-186. Lippincott Williams & Wilkins
Topical imiquimod could be an alternative, noninvasive, treatment modality for high-grade cervical intraepithelial neoplasia (CIN). However, evidence is limited, and there are no studies that compared treatment effectiveness and side effects of topic
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Supplemental tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ad719f25ece1ed7e1469c7d2d73bc
https://doi.org/10.1158/1078-0432.22475007.v1
https://doi.org/10.1158/1078-0432.22475007.v1
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Purpose:The tumor immune microenvironment determines clinical outcome. Whether the original tissue in which a primary tumor develops influences this microenvironment is not well understood.Experimental Design:We applied high-dimensional single-cell m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75cdfb8f59eb173ab207b11ae4743fee
https://doi.org/10.1158/1078-0432.c.6528966
https://doi.org/10.1158/1078-0432.c.6528966
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0674b04975698b1f0c374413fb4ea809
https://doi.org/10.1158/1078-0432.22475010.v1
https://doi.org/10.1158/1078-0432.22475010.v1
Autor:
Sjoerd H. van der Burg, Gemma G. Kenter, Sytse J. Piersma, Renske Goedemans, Jeanette M. van der Hulst, Margriet J. Löwik, Tamara H. Ramwadhdoebe, Moniek Heusinkveld, Peggy J. de Vos van Steenwijk
Supplementary Figure 1 from An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946296abfb4ef8da1e8514eb7684e8b4
https://doi.org/10.1158/0008-5472.22386437
https://doi.org/10.1158/0008-5472.22386437
Autor:
Sjoerd H. van der Burg, Gemma G. Kenter, Sytse J. Piersma, Renske Goedemans, Jeanette M. van der Hulst, Margriet J. Löwik, Tamara H. Ramwadhdoebe, Moniek Heusinkveld, Peggy J. de Vos van Steenwijk
Supplementary Table 1 from An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028eb2667f393dae32c42b82eaf6ea7a
https://doi.org/10.1158/0008-5472.22386431.v1
https://doi.org/10.1158/0008-5472.22386431.v1
Autor:
Sjoerd H. van der Burg, Gemma G. Kenter, Sytse J. Piersma, Renske Goedemans, Jeanette M. van der Hulst, Margriet J. Löwik, Tamara H. Ramwadhdoebe, Moniek Heusinkveld, Peggy J. de Vos van Steenwijk
Supplementary Figure Legend from An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ecefef2ba960c4262d9447559d6fb7b
https://doi.org/10.1158/0008-5472.22386434
https://doi.org/10.1158/0008-5472.22386434